Pliant Therapeutics, Inc. Share Price & Technical Analysis
PLRX · $1.21 (-1.63%)
Healthcare / Biotechnology
$1.21
-1.63%
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform co…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -7% avg return in past 3 year May month.
1% return in 2026, -40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 8% | 0% | -8% | 0% | – | – | – | – | – | – | – | 1% |
| 25 | -19% | -68% | -55% | 23% | -12% | -14% | 25% | 7% | -6% | 13% | -6% | -25% | -137% |
| 24 | 0% | -12% | -6% | -21% | 3% | -13% | 31% | -7% | -16% | 27% | -3% | -6% | -23% |
| 23 | 79% | -8% | -16% | 6% | -10% | -16% | -2% | -6% | 2% | -15% | -5% | 30% | 41% |
| 22 | -14% | -24% | -24% | -17% | -3% | 40% | 118% | 8% | 7% | 20% | -28% | 5% | 88% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$72.13M
P/E ratio
—
52W high
$1.95
52W low
$1.09
Volume
2,12,116
Beta
1.21
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Pliant Therapeutics, Inc. share price today?
- Pliant Therapeutics, Inc. (PLRX) last traded around $1.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PLRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PLRX. Download the app for real-time alerts.
- How can I analyze Pliant Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.